18 unknown, 16 completed, 2 not yet recruiting, 2 recruiting. 11 Not applicable, 11 Phase 3, 3 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Unknown 5, Completed 3, Recruiting 1, Suspended 1, Withdrawn 1 |
| Phase 3 | 11 | Completed 9, Recruiting 1, Unknown 1 |
| Phase 4 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Texas Cardiac Arrhythmia Research Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion Half-Dose of novel OAC, Low-dose ASA - Atrial Fibrillation (AF) | Phase 3 | Recruiting | Texas Cardiac Arrhythmia Research Foundation | 234 | 2026-09-01 | 2026-10-05 |
| The ORCHESTRATE-Myocarditis Registry Imaging - Myocarditis, Ischemia | Not yet recruiting | Kansas City Heart Rhythm Research Foundation | 382 | 2026-01-01 | 2025-08-28 | |
| Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation Atrial Fibrillation (AF) | Not yet recruiting | Texas Cardiac Arrhythmia Research Foundation | 162 | 2025-05-01 | 2025-03-17 | |
| Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT) Catheter ablation using pulsed-field ablation (PFA) system - Atrial Fibrillation | Terminated | Texas Cardiac Arrhythmia Research Foundation | 75 | 2024-08-29 | 2025-05-28 | |
| Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF Study arm - Atrial Fibrillation | Not applicable | Recruiting | Texas Cardiac Arrhythmia Research Foundation | 184 | 2022-08-22 | 2026-09-14 |
| Esophageal Protection Study: A Multicenter Study ensoETM. Esophageal cooling during AF ablation, Esophageal temperature monitoring probe - AF - Atrial Fibrillation, Complication | Not applicable | Completed | Advanced Cooling Therapy LLC, d/b/a Attune Medical | 152 | 2022-03-10 | 2026-07-08 |
| Natural History of COVID-19-Related Atrial Fibrillation ILR, PMK, ICD - COVID-19, Atrial Fibrillation New Onset | Not applicable | Unknown | Texas Cardiac Arrhythmia Research Foundation | 200 | 2021-04-15 | 2021-11-23 |
| RF Applications for Residual LAA Leaks Radiofrequency Energy Applications - Left Atrial Appendage Thrombosis, Stroke, Ischemic | Not applicable | Unknown | Texas Cardiac Arrhythmia Research Foundation | 100 | 2021-02-01 | 2021-02-11 |
| Immune Response Following COVID-19 Vaccination Rapid antibody test - IgM and IgG in Blood | Unknown | Texas Cardiac Arrhythmia Research Foundation | 500 | 2021-01-15 | 2021-02-03 | |
| Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation - Arrhythmias, Cardiac, Atrial Fibrillation | Phase 4 | Unknown | Kansas City Heart Rhythm Research Foundation | 80 | 2021-01-02 | 2022-01-14 |
| Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function Whole exome sequencing - Covid19 | Unknown | Texas Cardiac Arrhythmia Research Foundation | 60 | 2020-08-20 | 2020-08-27 | |
| Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion ASA plus Clopidogrel, Genetic-Tailored AntiThrombotic Strategy, Half-Dose of novel OAC - Device-Related Thrombosis, Atrial Fibrillation | Phase 4 | Unknown | Texas Cardiac Arrhythmia Research Foundation | 360 | 2020-08-05 | 2020-08-07 |
| Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk Hydroxychloroquine Sulfate - COVID-19 | Not applicable | Withdrawn | Texas Cardiac Arrhythmia Research Foundation | 2020-06-01 | 2020-06-04 | |
| Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) diagnostic tests for COVID-19 infection - COVID-19 | Phase 1 | Unknown | Texas Cardiac Arrhythmia Research Foundation | 100 | 2020-05-08 | 2020-08-11 |
| ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test - Covid19 | Unknown | Texas Cardiac Arrhythmia Research Foundation | 5000 | 2020-03-27 | 2020-04-27 | |
| Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation Thromboembolic Events | Unknown | Texas Cardiac Arrhythmia Research Foundation | 40 | 2019-10-01 | 2019-10-17 | |
| First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3) Anti Arrhythmics, Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation - Atrial Fibrillation | Phase 3 | Completed | University of Pennsylvania | 25 | 2019-09-24 | 2024-11-12 |
| Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation Half-normal saline, Normal saline - Ventricular Arrythmia | Not applicable | Suspended | Texas Cardiac Arrhythmia Research Foundation | 50 | 2018-05-16 | 2022-04-11 |
| Half-normal Saline in Atrial Fibrillation Ablation Half-normal saline, Normal saline - Atrial Fibrillation | Not applicable | Completed | Texas Cardiac Arrhythmia Research Foundation | 99 | 2018-05-02 | 2022-04-05 |
| Transcatheter Leak Closure With Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures Interlock-35 Fibered IDC Occlusion System, Concerto Helix Detachable Coil System, Azur Peripheral Coil System - Left Atrial Appendage Incomplete Closure | Not applicable | Unknown | Texas Cardiac Arrhythmia Research Foundation | 120 | 2018-04-09 | 2021-04-06 |
Showing 20 of 41. Sign in to see all of them.
Atrial Fibrillation (26) · COVID-19 (5) · Stroke (3) · Thromboembolism (2) · Arrhythmias, Cardiac (1) · Cardiomyopathy, Dilated (1) · Chest Pain (1) · Cognitive Dysfunction (1) · Death, Sudden, Cardiac (1) · Dementia (1) · Heart Failure (1) · Hyper-IgM Immunodeficiency Syndrome, Type 1 (1) · Ischemia (1) · Ischemic Stroke (1) · Migraine Disorders (1)
Catheter Ablation (8) · Amiodarone (2) · Saline Solution (2) · Anti-Arrhythmia Agents (1) · Aspirin (1) · BID protein, human (1) · Clopidogrel (1) · Defibrillators, Implantable (1) · Diagnostic Imaging (1) · Diagnostic Tests, Routine (1) · Drug Delivery Systems (1) · Exome Sequencing (1) · Hydroxychloroquine (1) · Neuropsychological Tests (1) · Warfarin (1)
United States (39) · Italy (2) · Belgium (1) · Canada (1) · United Kingdom (1)
Andrea Natale, MD (22) · Andrea Natale (5) · Mitra Mohanty, MD (3) · Luigi Di Biase, MD, PhD (2) · Andrea Natale, MD FACC FHRS (1) · Claudio Tondo, MD (1) · David Callans, MD (1) · Dhanunjaya Lakkireddy (1) · Dhanunjaya Lakkireddy, MD (1) · Domenico G Della Rocca, MD (1) · Luigi Di Biase, MD, Phd (1) · Luigi Di Biase, Md, PhD (1) · Mitra Mohanty, MD MS FHRS (1) · Rong Bai, MD (1) · Sanghamitra Mohanty (1)
PMID 21955215, PMID 23572499, PMID 24744272, PMID 24903064, PMID 25460855, PMID 26277862, PMID 26497660, PMID 26718674, PMID 27029350, PMID 27163758, PMID 27788847, PMID 30144981, PMID 31954677, PMID 33006086, PMID 33870705, PMID 34330671, PMID 34674223, PMID 37014289